Medipal Holdings (TSE:7459) LT-Debt-to-Total-Asset: 0.00 (As of Mar. 2026)

What is Medipal Holdings LT-Debt-to-Total-Asset?

Medipal Holdings TSE:7459 -2.82% 81 LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus rates TSE:7459 with a GF Score™ of 81/100 and a GF Value™ of 円2,732.17 (Fairly Valued). The stock has 1 warning sign investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Medipal Holdings's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.00.

Medipal Holdings's long-term debt to total assets ratio stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00).

Medipal Holdings (TSE:7459) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Medipal Holdings LT-Debt-to-Total-Asset Related Terms

Medipal Holdings LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Medipal Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medipal Holdings LT-Debt-to-Total-Asset Chart

Medipal Holdings Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.00

Medipal Holdings Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

81GF Score

Medipal Holdings Corp TSE:7459

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Medipal Holdings LT-Debt-to-Total-Asset Calculation

Medipal Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )	/	Total Assets (A: Mar. 2026 )
	=	0	/	1922002
	=	0.00

Medipal Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	0	/	1922002
	=	0.00

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.00 mean?

Medipal Holdings (TSE:7459) has a LT-Debt-to-Total-Asset of 0.00 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Medipal Holdings and its competitors.

Is Medipal Holdings' LT-Debt-to-Total-Asset too high?

Medipal Holdings' current LT-Debt-to-Total-Asset is 0.00. Overall, Medipal Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Medipal Holdings' LT-Debt-to-Total-Asset compare to MCK and CAH?

Medipal Holdings' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Distribution company?

A good LT-Debt-to-Total-Asset depends on the Medical Distribution industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Medipal Holdings and its competitors. Medipal Holdings's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Medipal Holdings stock overvalued right now?

Based on GuruFocus' analysis, Medipal Holdings (TSE:7459) is currently considered Fairly Valued. The stock's GF Value™ is 円2,732.17, compared to a current price of 円2,636.00 — trading 3.5% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Medipal Holdings' overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Medipal Holdings (TSE:7459), the current LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medipal Holdings (TSE:7459) Overvalued in 2026?

Based on GuruFocus' analysis, Medipal Holdings stock appears to be undervalued. The current stock price of 円2,636.00 is trading 3.5% below its estimated GF Value™ of 円2,732.17. GuruFocus considers Medipal Holdings to be Fairly Valued.

Key valuation signals for TSE:7459:

LT-Debt-to-Total-Asset: 0.00
GF Value™: 円2,732.17 vs. price of 円2,636.00 (3.5% below fair value)
GF Score™: 81/100 with 1 warning sign

No single metric tells the full story. See the TSE:7459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medipal Holdings Business Description

Industry Healthcare Medical Distribution

Comparable Companies TSE:2784 TSE:9987 TSE:8129 TSE:7476 TSE:3151 TSE:3183 NGO:7488 SSE:3055 TSE:7634 TSE:2689 MCK CAH COR ASX:SIG HSIC SHSE:601607 HKSE:01099 XSWX:GALE SHSE:600332 SHSE:600998

Other Exchanges MEPDF:USA MAHLY:USA

Address 3-1-1 Kyobashi, Chuo-ku, Tokyo, JPN, 104-8461

Website https://www.medipal.co.jp

Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.

81GF Score

Get the complete analysis for TSE:7459

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,636.00

Price

円2,732.17

GF Value

View TSE:7459 Analysis

See LT-Debt-to-Total-Asset data for all stocks →